Six cases of primary colorectal cancer after living-donor liver transplantation: a single-institution experience in Japan.

OBJECTIVE Liver-transplant patients have an increased risk of developing primary malignancies, possibly due to prolonged immunosuppression. However, no information on the incidence and biological characteristics of colorectal cancer after living-donor liver transplantation is available. METHODS The medical records of 392 consecutive adult patients who had undergone living-donor liver transplantation were retrospectively analyzed. RESULTS Colorectal cancer developed in 6 (1.5%) patients; 3 of 204 (1.5%) presented with hepatic cirrhosis, 2 of 77 (2.5%) with primary biliary cirrhosis and 1 (2.6%) of 39 with subacute fulminant hepatitis, but none of 13 patients with primary sclerosing cholangitis. Four patients were successfully treated with curative surgery and one with endoscopic resection, while another patient died 3 months after palliative surgery because of the progression of peritoneal metastasis. A pathological study revealed vessel invasion in all the five cases of surgically removed colorectal cancer and nodal metastasis in four (80%) cases. CONCLUSIONS Colorectal cancer develops at a relatively high frequency after living-donor liver transplantation, even in non-primary sclerosing cholangitis cases, and might have high malignant potential. The screening program for colorectal cancer should be more intensified after living-donor liver transplantation compared with that in the general population.

[1]  R. Lopez,et al.  Risk of Colonic Neoplasia After Liver Transplantation for Primary Sclerosing Cholangitis , 2012, Inflammatory bowel diseases.

[2]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[3]  E. Kuipers,et al.  Risk of Colorectal Carcinoma in Post‐Liver Transplant Patients: A Systematic Review and Meta‐analysis , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.

[5]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[6]  J. Prieto,et al.  Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report , 2009, Clinical transplantation.

[7]  R. Sankila,et al.  Risk of malignant neoplasms after liver transplantation: A population‐based study , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  Y. Ohno,et al.  Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries. , 2008, Japanese journal of clinical oncology.

[9]  H. Takikawa Characteristics of primary sclerosing cholangitis in Japan , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  J. Pirsch,et al.  A 30-Year Analysis of Colorectal Adenocarcinoma in Transplant Recipients and Proposal for Altered Screening , 2007, Journal of Gastrointestinal Surgery.

[11]  J. Ferlay,et al.  Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  L. Vizzotto,et al.  De novo cancers and post‐transplant lymphoproliferative disorder in adult liver transplantation , 2006, Pathology international.

[13]  D. Mirza,et al.  Colorectal cancer after orthotopic liver transplantation. , 2005, Critical reviews in oncology/hematology.

[14]  J. Neuberger,et al.  Incidence of Cancers Following Orthotopic Liver Transplantation in a Single Center: Comparison with National Cancer Incidence Rates for England and Wales , 2005, Transplantation.

[15]  R. Alloway,et al.  De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. , 2005, Transplantation proceedings.

[16]  J. Neuberger,et al.  Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis , 2003, Transplantation.

[17]  G. Klintmalm,et al.  De novo tumors after liver transplantation: A single‐institution experience , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  T. Serrano,et al.  Risk factors for development of de novo neoplasia after liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  G. Arpesella,et al.  De novo malignancies after organ transplantation. , 2001, Transplantation proceedings.

[20]  F. Roudot-thoraval,et al.  Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. , 1999, Transplantation.

[21]  J. Reyes,et al.  Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. , 1998, Transplantation.

[22]  M. Schwartz,et al.  Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors , 1998, Cancer.

[23]  G. Klintmalm,et al.  Colon carcinoma in patients undergoing liver transplantation. , 1998, American journal of surgery.

[24]  A. Zinsmeister,et al.  Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation , 1998, Hepatology.

[25]  D. V. van Thiel,et al.  Non-lymphoid cancer after liver transplantation. , 1997, Hepato-gastroenterology.

[26]  R. Busuttil,et al.  Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. , 1997, Annals of surgery.

[27]  S. Knechtle,et al.  Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. , 1995, Surgery.

[28]  I. Penn,et al.  Cancer in the immunosuppressed organ recipient. , 1991, Transplantation proceedings.

[29]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[30]  H. Higashi,et al.  Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis , 1990, Hepatology.

[31]  T. Starzl,et al.  Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis , 1988, Annals of surgery.

[32]  T. Starzl,et al.  Malignant tumors arising de novo in immunosuppressed organ transplant recipients. , 1972 .

[33]  T. Starzl,et al.  Malignant lymphomas in transplantation patients. , 1969, Transplantation proceedings.

[34]  J. H. Harrison,et al.  Five Years' Experience in Renal Transplantation with Immunosuppressive Drugs: Survival, Function, Complications, and the Role of Lymphocyte Depletion by Thoracic Duct Fistula , 1968, Annals of surgery.

[35]  Daniele Marchioni,et al.  A Single-Institution Experience , 2013 .

[36]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer , 2011, International Journal of Clinical Oncology.

[37]  S. Raab Objective Criteria for the Grading of Venous Invasion in Colorectal Cancer , 2011 .

[38]  W. Ajiki,et al.  Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2011, Japanese journal of clinical oncology.

[39]  B. Müllhaupt,et al.  Should we screen for colorectal cancer in liver transplantation? , 2006, Journal of hepatology.

[40]  A. Zaman For Primary Sclerosing Cholangitis, the Diagnostic Accuracy of MRC and ERC Is Similar , 2006 .

[41]  H. Takikawa,et al.  Primary sclerosing cholangitis in Japan—analysis of 192 cases , 2005, Journal of Gastroenterology.

[42]  E. D. de Vries,et al.  Increased cancer risk after liver transplantation: a population-based study. , 2001, Journal of hepatology.

[43]  A. Ekbom Ulcerative Colitis and Colorectal Cancer , 1991 .

[44]  H. Rajoana [Alcoholic cirrhosis]. , 1970, Revue de l'infirmiere et de l'assistante sociale.